Spotlight On... Indian hospitals pioneering use of 'eICUs' to combat doctor shortage; Hospitals hire Philips to predict fall risk for elderly patients; Withings launches personalized blood pressure app; and more...

Indian doctors recently saved the life of a 30-year-old woman by instructing an unspecialized doctor about chest compressions over Internet-enabled video. The country's private hospital chains such as Fortis and Apollo plan to expand the number of so-called eICU beds by about 20% a year, from about 3,000 beds right now. "We save about 25 lives a month," said Shamit Gupta, medical director at Fortis' eICU unit. More

@FierceMedDev: Sientra resumes U.S. sales of breast implants after Brazil manufacturing fallout. Report | Follow @FierceMedDev

@EmilyWFierce: ICYMI from FiercePharma: PhRMA kicks off new ad campaign to doctor pharma's tarred image. Article | Follow @EmilyWFierce

> Royal Philips ($PHG) has secured a contract with Henry Ford Health System to provide its LifeLine technology powered by predictive analytics engine CareSage to help identify elderly patients that are at-risk of falling over the 30-day after hospital discharge. This is its eighth such U.S. hospital deal by Philips in the last 6 months. More

> Withings has launched an app to offer personalized, algorithmic analysis of blood pressure data from in-home monitors, including its own. More

> CorMatrix Cardiovascular has nabbed FDA clearance for its Tyke, an infant or neonate implant for the repair of pericardial structures, a patch for intracardiac defects, septal defects and annulus repair, suture-line buttressing, and cardiac repair. More

Biotech News

@FierceBiotech: Amplyx ups its B round to $49.2M on the way to the clinical with an antifungal drug. Article | Follow @FierceBiotech

@JohnCFierce: Are the big M&A players in biopharma (like Sanofi/Gilead/Biogen) waiting out the bear market? More | Follow @JohnCFierce

@DamianFierce: Thesis of this BIO thing is that you can't put $ on life, but doesn't pricing onco drugs based on OS do just that? | Follow @DamianFierce

> Apellis pulls its IPO as biotech bears rampage on Wall Street. Item

> OrbiMed founder preaches patience amid a biotech slump. Report

> In wake of $1B Celgene deal, Juno sweetens 2015 bonuses for CEO, CFO. Article

Pharma News

@FiercePharma: Omega diet-aid ad banned in U.K.; summer slimming promos not 'socially responsible.' FiercePharmaMarketing article | Follow @FiercePharma

@CarlyHFierce: All I want is to hear two people pronounce "Praluent" the same way. $REGN | Follow @CarlyHFierce

> Top Senate Democrat grills HHS about opioid panel's alleged ties to industry. Article

> Sanofi's outlook less than sunny as key diabetes franchise continues to sag. Report

Pharma Manufacturing News

> Plant to manufacture yellow fever jab slated for Dakar. More

> FDA quality focus will definitely mean winners and losers, report says. Report

> Dr. Reddy's grows U.S. sales even in face of FDA action. Story

> Report says CMOs without U.S. facilities risk being left out of 'hot' market. Item

> Strides Shasun deals adds seventh plant to its African production network. Article

Pharma Asia News

> China Resources Pharmaceutical plans HK IPO. News

> Taiwan's outgoing leader touts biotech growth. Story

> Japan's Eisai surprises with API move. Item

> Japan continues to see generics as way to ease healthcare costs. Report

> Novo says China price pressures may go into 2017. Article

Drug Delivery News

> 'Crystal balls' in drug delivery could be stronger than liposomes. More

> Novartis signs with France's MedinCell for controlled-release injection tech. Story

> FDA says drug delivery devices need human factors validation testing. Item

> Struggling Unilife extends negotiating period with Amgen over partial takeover. Report

> Scilex aims to dethrone Endo in billion-dollar pain subsegment using novel transdermal patch. Article